Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Calcagno

Showing results (21-30 of 258) with videos related to

Pageof 26
Sort By:
Expert Opinion on Pharmacotherapy|December 8, 2015
Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adultsStefano Bonora, Andrea Calcagno, Alice Trentalange, et al.
Parasitology|January 8, 2026
Neurocognitive effects of latent <i>Toxoplasma gondii</i> infection in immunocompromised people with HIVDaniela Rovito, Stefania Zanet, Mattia Trunfio, et al.
Current Topics in Behavioral Neurosciences|February 19, 2021
Clinical Treatment Options and Randomized Clinical Trials for Neurocognitive Complications of HIV Infection: Combination Antiretroviral Therapy, Central Nervous System Penetration Effectiveness, and AdjuvantsShih-Ping Lin, Andrea Calcagno, Scott L Letendre, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2010
Raltegravir: is a 400 mg once-daily dose enough?Massimiliano Lanzafame, Andrew Hill, Emanuela Lattuada, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|January 11, 2012
A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patientsMassimiliano Lanzafame, Stefano Bonora, Emanuela Lattuada, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 21, 2015
Acute HIV infection: improved algorithms for HIV testingValeria Ghisetti, Andrea Calcagno, Elisa Burdino, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 29, 2021
The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIVAndrea Calcagno, Mattia Trunfio, Antonio D'Avolio, et al.
Journal of Neurovirology|August 2, 2020
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugsIlaria De Benedetto, Mattia Trunfio, Giulia Guastamacchia, et al.
Pharmacogenomics|December 6, 2017
Precision medicine for HIV: where are we?Jessica Cusato, Sarah Allegra, Amedeo De Nicolò, et al.
AIDS Reviews|July 24, 2019
Malignant Melanoma in People Living with HIV/AIDS: Can We Know More, Can We Do Better?Mattia Trunfio, Simone Ribero, Stefano Bonora, et al.
Pageof 26

Showing results (21-30 of 258) with videos related to

Sort By:
Pageof 26
Expert Opinion on Pharmacotherapy|December 8, 2015
Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adultsStefano Bonora, Andrea Calcagno, Alice Trentalange, et al.
Parasitology|January 8, 2026
Neurocognitive effects of latent <i>Toxoplasma gondii</i> infection in immunocompromised people with HIVDaniela Rovito, Stefania Zanet, Mattia Trunfio, et al.
Current Topics in Behavioral Neurosciences|February 19, 2021
Clinical Treatment Options and Randomized Clinical Trials for Neurocognitive Complications of HIV Infection: Combination Antiretroviral Therapy, Central Nervous System Penetration Effectiveness, and AdjuvantsShih-Ping Lin, Andrea Calcagno, Scott L Letendre, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2010
Raltegravir: is a 400 mg once-daily dose enough?Massimiliano Lanzafame, Andrew Hill, Emanuela Lattuada, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|January 11, 2012
A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patientsMassimiliano Lanzafame, Stefano Bonora, Emanuela Lattuada, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 21, 2015
Acute HIV infection: improved algorithms for HIV testingValeria Ghisetti, Andrea Calcagno, Elisa Burdino, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 29, 2021
The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIVAndrea Calcagno, Mattia Trunfio, Antonio D'Avolio, et al.
Journal of Neurovirology|August 2, 2020
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugsIlaria De Benedetto, Mattia Trunfio, Giulia Guastamacchia, et al.
Pharmacogenomics|December 6, 2017
Precision medicine for HIV: where are we?Jessica Cusato, Sarah Allegra, Amedeo De Nicolò, et al.
AIDS Reviews|July 24, 2019
Malignant Melanoma in People Living with HIV/AIDS: Can We Know More, Can We Do Better?Mattia Trunfio, Simone Ribero, Stefano Bonora, et al.
Pageof 26